Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

Javier Carmona¹, Elena Chavarria¹, Kate Donoghue², Christina von Gertten³, Petra Oberrauch^{4

5}, Emma Pailler⁶, Giovanni Scoazec⁷, Ruud Weijer⁸, Judith Balmaña^{1

9}, Irene Brana^{1

9}, Cinzia Brunelli¹⁰, Suzette Delaloge¹¹, Marc Deloger⁶, Pierre Delpy^{12

13

14}, Ingemar Ernberg¹⁵, Rebecca C Fitzgerald¹⁶, Elena Garralda^{1

9}, Martin Lablans^{12

13

14}, Janne Lëhtio^{17

18}, Carlos Lopez¹, Maialen Fernández¹, Rosalba Miceli¹⁹, Paolo Nuciforo¹, Raquel Perez-Lopez¹, Elena Provenzano², Marjanka K Schmidt²⁰, Cesar Serrano^{1

9}, Neeltje Steeghs²¹, David Tamborero^{17

18}, Valtteri Wirta^{22

23}, Richard D Baird², Karen Barker², Fabrice Barlesi^{6

24}, Michael Baumann^{4

5

25}, Jonas Bergh^{3

26}, Filippo de Braud⁷, Karim Fizazi⁶, Stefan Fröhling^{4

5

25

27}, Alejandro Piris-Giménez¹, Kenneth Seamon², Michiel S Van der Heijden⁸, Wilbert Zwart^{8

28}, Josep Tabernero^{1

9}

Affiliations

¹ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
³ Karolinska Institutet, Stockholm, Sweden.
⁴ German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁵ National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
⁶ Gustave Roussy, Villejuif, France.
⁷ Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
⁸ Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁹ Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
¹⁰ Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
¹¹ Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
¹² Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³ Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
¹⁴ German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
¹⁵ Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden.
¹⁶ Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
¹⁷ Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
¹⁸ Karolinska University Hospital, Stockholm, Sweden.
¹⁹ Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
²⁰ Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands.
²¹ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
²² Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden.
²³ Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
²⁴ Paris Saclay University, Villejuif, France.
²⁵ German Cancer Consortium (DKTK), Heidelberg, Germany.
²⁶ Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Solna, Sweden.
²⁷ Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
²⁸ Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.

PMID: 38870393
DOI: 10.1158/2159-8290.CD-24-0377

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

Javier Carmona et al. Cancer Discov. 2024.

. 2024 Jul 1;14(7):1147-1153.

doi: 10.1158/2159-8290.CD-24-0377.

Authors

Affiliations

¹ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
³ Karolinska Institutet, Stockholm, Sweden.
⁴ German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁵ National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
⁶ Gustave Roussy, Villejuif, France.
⁷ Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
⁸ Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁹ Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
¹⁰ Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
¹¹ Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
¹² Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³ Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
¹⁴ German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
¹⁵ Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden.
¹⁶ Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
¹⁷ Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
¹⁸ Karolinska University Hospital, Stockholm, Sweden.
¹⁹ Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
²⁰ Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands.
²¹ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
²² Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden.
²³ Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
²⁴ Paris Saclay University, Villejuif, France.
²⁵ German Cancer Consortium (DKTK), Heidelberg, Germany.
²⁶ Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Solna, Sweden.
²⁷ Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
²⁸ Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.

PMID: 38870393
DOI: 10.1158/2159-8290.CD-24-0377

Abstract

Cancer Core Europe brings together the expertise, resources, and interests of seven leading cancer institutes committed to leveraging collective innovation and collaboration in precision oncology. Through targeted efforts addressing key medical challenges in cancer and partnerships with multiple stakeholders, the consortium seeks to advance cancer research and enhance equitable patient care.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

Affiliations

Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally

Authors

Affiliations

Abstract

MeSH terms

LinkOut - more resources

Full Text Sources

Medical